CHDI’s goal is to increase the understanding of Huntington’s disease (HD) and to hasten the development of therapies. We collaborate with academic and industrial scientists throughout the world.
This website highlights activities that may be of particular interest to people engaged in or contemplating HD research and provides information on targets, compounds, and research materials that HD researchers may find useful.
Please join our mailing list.
AMRI Commences Drug Discovery Collaboration
AMRI (NASDAQ: AMRI) and CHDI Foundation, Inc., a non-profit organization pursuing drugs that delay or slow Huntington’s disease (HD), announced today the commencement of a new collaboration agreement focused on the discovery of new therapeutic agents for the treatment of this disease.
GlobalStem and CHDI Foundation sign agreement
Partnership will provide researchers with fully-authenticated supply of single-mutant cell culture models of Huntington’s disease.
World Congress for Huntington's Disease
Members of the Huntington’s Disease community from around the world convene to discuss research and clinical opportunities for research.
HDSA National Convention
The 24th Annual Convention for the Huntington's Disease Society of America.
2009 Gordon Conference
The CAG Triplet Repeat Disorders Gordon Research Conference will be held in conjunction with the CAG Triplet Repeat Disorders Gordon-Kenan Research Seminar.
Except as otherwise noted, content on this site is licensed under a
Creative Commons Attribution 3.0 United States License.